Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 Oct;69(4):433–441. doi: 10.1136/jnnp.69.4.433

Cerebral malaria

C Newton 1, T T Hien 1, N White 1
PMCID: PMC1737146  PMID: 10990500

Abstract

Cerebral malaria may be the most common non-traumatic encephalopathy in the world. The pathogenesis is heterogenous and the neurological complications are often part of a multisystem dysfunction. The clinical presentation and pathophysiology differs between adults and children. Recent studies have elucidated the molecular mechanisms of pathogenesis and raised possible interventions. Antimalarial drugs, however, remain the only intervention that unequivocally affects outcome, although increasing resistance to the established antimalarial drugs is of grave concern. Artemisinin derivatives have made an impact on treatment, but other drugs may be required. With appropriate antimalarial drugs, the prognosis of cerebral malaria often depends on the management of other complications—for example, renal failure and acidosis. Neurological sequelae are increasingly recognised, but further research on the pathogenesis of coma and neurological damage is required to develop other ancillary treatments.



Full Text

The Full Text of this article is available as a PDF (151.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agbenyega T., Angus B., Bedu-Addo G., Baffoe-Bonnie B., Griffin G., Vallance P., Krishna S. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria. Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):298–302. doi: 10.1016/s0035-9203(97)90083-3. [DOI] [PubMed] [Google Scholar]
  2. Al Yaman F. M., Mokela D., Genton B., Rockett K. A., Alpers M. P., Clark I. A. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Trans R Soc Trop Med Hyg. 1996 May-Jun;90(3):270–273. doi: 10.1016/s0035-9203(96)90243-6. [DOI] [PubMed] [Google Scholar]
  3. Anstey N. M., Weinberg J. B., Wang Z., Mwaikambo E. D., Duffy P. E., Granger D. L. Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children. Am J Trop Med Hyg. 1999 Aug;61(2):253–258. doi: 10.4269/ajtmh.1999.61.253. [DOI] [PubMed] [Google Scholar]
  4. Barragan A., Spillmann D., Kremsner P. G., Wahlgren M., Carlson J. Plasmodium falciparum: molecular background to strain-specific rosette disruption by glycosaminoglycans and sulfated glycoconjugates. Exp Parasitol. 1999 Feb;91(2):133–143. doi: 10.1006/expr.1998.4349. [DOI] [PubMed] [Google Scholar]
  5. Bellamy R., Kwiatkowski D., Hill A. V. Absence of an association between intercellular adhesion molecule 1, complement receptor 1 and interleukin 1 receptor antagonist gene polymorphisms and severe malaria in a West African population. Trans R Soc Trop Med Hyg. 1998 May-Jun;92(3):312–316. doi: 10.1016/s0035-9203(98)91026-4. [DOI] [PubMed] [Google Scholar]
  6. Berendt A. R., Ferguson D. J., Gardner J., Turner G., Rowe A., McCormick C., Roberts D., Craig A., Pinches R., Elford B. C. Molecular mechanisms of sequestration in malaria. Parasitology. 1994;108 (Suppl):S19–S28. doi: 10.1017/s0031182000075685. [DOI] [PubMed] [Google Scholar]
  7. Berendt A. R., Simmons D. L., Tansey J., Newbold C. I., Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 1989 Sep 7;341(6237):57–59. doi: 10.1038/341057a0. [DOI] [PubMed] [Google Scholar]
  8. Bondi F. S. The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long-term follow-up of 62 survivors. Trans R Soc Trop Med Hyg. 1992 Jan-Feb;86(1):17–19. doi: 10.1016/0035-9203(92)90420-h. [DOI] [PubMed] [Google Scholar]
  9. Borst P., Bitter W., McCulloch R., Van Leeuwen F., Rudenko G. Antigenic variation in malaria. Cell. 1995 Jul 14;82(1):1–4. doi: 10.1016/0092-8674(95)90044-6. [DOI] [PubMed] [Google Scholar]
  10. Brewster D. R., Kwiatkowski D., White N. J. Neurological sequelae of cerebral malaria in children. Lancet. 1990 Oct 27;336(8722):1039–1043. doi: 10.1016/0140-6736(90)92498-7. [DOI] [PubMed] [Google Scholar]
  11. Brown H., Hien T. T., Day N., Mai N. T., Chuong L. V., Chau T. T., Loc P. P., Phu N. H., Bethell D., Farrar J. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999 Aug;25(4):331–340. doi: 10.1046/j.1365-2990.1999.00188.x. [DOI] [PubMed] [Google Scholar]
  12. Carlson J., Helmby H., Hill A. V., Brewster D., Greenwood B. M., Wahlgren M. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet. 1990 Dec 15;336(8729):1457–1460. doi: 10.1016/0140-6736(90)93174-n. [DOI] [PubMed] [Google Scholar]
  13. Clark I. A., Rockett K. A., Cowden W. B. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet. 1992 Oct 10;340(8824):894–896. doi: 10.1016/0140-6736(92)93295-x. [DOI] [PubMed] [Google Scholar]
  14. Clavier N., Rahimy C., Falanga P., Ayivi B., Payen D. No evidence for cerebral hypoperfusion during cerebral malaria. Crit Care Med. 1999 Mar;27(3):628–632. doi: 10.1097/00003246-199903000-00047. [DOI] [PubMed] [Google Scholar]
  15. Cranston H. A., Boylan C. W., Carroll G. L., Sutera S. P., Williamson J. R., Gluzman I. Y., Krogstad D. J. Plasmodium falciparum maturation abolishes physiologic red cell deformability. Science. 1984 Jan 27;223(4634):400–403. doi: 10.1126/science.6362007. [DOI] [PubMed] [Google Scholar]
  16. Crawley J., English M., Waruiru C., Mwangi I., Marsh K. Abnormal respiratory patterns in childhood cerebral malaria. Trans R Soc Trop Med Hyg. 1998 May-Jun;92(3):305–308. doi: 10.1016/s0035-9203(98)91023-9. [DOI] [PubMed] [Google Scholar]
  17. Crawley J., Smith S., Kirkham F., Muthinji P., Waruiru C., Marsh K. Seizures and status epilepticus in childhood cerebral malaria. QJM. 1996 Aug;89(8):591–597. doi: 10.1093/qjmed/89.8.591. [DOI] [PubMed] [Google Scholar]
  18. Davis T. M., Krishna S., Looareesuwan S., Supanaranond W., Pukrittayakamee S., Attatamsoonthorn K., White N. J. Erythrocyte sequestration and anemia in severe falciparum malaria. Analysis of acute changes in venous hematocrit using a simple mathematical model. J Clin Invest. 1990 Sep;86(3):793–800. doi: 10.1172/JCI114776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Davis T. M., Supanaranond W., Pukrittayakamee S., Karbwang J., Molunto P., Mekthon S., White N. J. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis. 1990 Jun;161(6):1305–1308. doi: 10.1093/infdis/161.6.1305. [DOI] [PubMed] [Google Scholar]
  20. Day N. P., Hien T. T., Schollaardt T., Loc P. P., Chuong L. V., Chau T. T., Mai N. T., Phu N. H., Sinh D. X., White N. J. The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis. 1999 Oct;180(4):1288–1297. doi: 10.1086/315016. [DOI] [PubMed] [Google Scholar]
  21. Di Perri G., Di Perri I. G., Monteiro G. B., Bonora S., Hennig C., Cassatella M., Micciolo R., Vento S., Dusi S., Bassetti D. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis. 1995 May;171(5):1317–1322. doi: 10.1093/infdis/171.5.1317. [DOI] [PubMed] [Google Scholar]
  22. Dondorp A. M., Angus B. J., Hardeman M. R., Chotivanich K. T., Silamut K., Ruangveerayuth R., Kager P. A., White N. J., Vreeken J. Prognostic significance of reduced red blood cell deformability in severe falciparum malaria. Am J Trop Med Hyg. 1997 Nov;57(5):507–511. doi: 10.4269/ajtmh.1997.57.507. [DOI] [PubMed] [Google Scholar]
  23. English M., Waruiru C., Marsh K. Transfusion for respiratory distress in life-threatening childhood malaria. Am J Trop Med Hyg. 1996 Nov;55(5):525–530. doi: 10.4269/ajtmh.1996.55.525. [DOI] [PubMed] [Google Scholar]
  24. Fernandez-Reyes D., Craig A. G., Kyes S. A., Peshu N., Snow R. W., Berendt A. R., Marsh K., Newbold C. I. A high frequency African coding polymorphism in the N-terminal domain of ICAM-1 predisposing to cerebral malaria in Kenya. Hum Mol Genet. 1997 Aug;6(8):1357–1360. doi: 10.1093/hmg/6.8.1357. [DOI] [PubMed] [Google Scholar]
  25. Fujioka H., Aikawa M. The molecular basis of pathogenesis of cerebral malaria. Microb Pathog. 1996 Feb;20(2):63–72. doi: 10.1006/mpat.1996.0006. [DOI] [PubMed] [Google Scholar]
  26. Gordeuk V., Thuma P., Brittenham G., McLaren C., Parry D., Backenstose A., Biemba G., Msiska R., Holmes L., McKinley E. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med. 1992 Nov 19;327(21):1473–1477. doi: 10.1056/NEJM199211193272101. [DOI] [PubMed] [Google Scholar]
  27. Grau G. E., Taylor T. E., Molyneux M. E., Wirima J. J., Vassalli P., Hommel M., Lambert P. H. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989 Jun 15;320(24):1586–1591. doi: 10.1056/NEJM198906153202404. [DOI] [PubMed] [Google Scholar]
  28. Hien T. T., Arnold K., Vinh H., Cuong B. M., Phu N. H., Chau T. T., Hoa N. T., Chuong L. V., Mai N. T., Vinh N. N. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):582–583. doi: 10.1016/0035-9203(92)90137-2. [DOI] [PubMed] [Google Scholar]
  29. Hien T. T., White N. J. Qinghaosu. Lancet. 1993 Mar 6;341(8845):603–608. doi: 10.1016/0140-6736(93)90362-k. [DOI] [PubMed] [Google Scholar]
  30. Ho M., Singh B., Looareesuwan S., Davis T. M., Bunnag D., White N. J. Clinical correlates of in vitro Plasmodium falciparum cytoadherence. Infect Immun. 1991 Mar;59(3):873–878. doi: 10.1128/iai.59.3.873-878.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hoffman S. L., Rustama D., Punjabi N. H., Surampaet B., Sanjaya B., Dimpudus A. J., McKee K. T., Jr, Paleologo F. P., Campbell J. R., Marwoto H. High-dose dexamethasone in quinine-treated patients with cerebral malaria: a double-blind, placebo-controlled trial. J Infect Dis. 1988 Aug;158(2):325–331. doi: 10.1093/infdis/158.2.325. [DOI] [PubMed] [Google Scholar]
  32. Holding P. A., Stevenson J., Peshu N., Marsh K. Cognitive sequelae of severe malaria with impaired consciousness. Trans R Soc Trop Med Hyg. 1999 Sep-Oct;93(5):529–534. doi: 10.1016/s0035-9203(99)90368-1. [DOI] [PubMed] [Google Scholar]
  33. Karunaweera N. D., Grau G. E., Gamage P., Carter R., Mendis K. N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3200–3203. doi: 10.1073/pnas.89.8.3200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kaul D. K., Liu X. D., Nagel R. L., Shear H. L. Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria. Am J Trop Med Hyg. 1998 Feb;58(2):240–247. doi: 10.4269/ajtmh.1998.58.240. [DOI] [PubMed] [Google Scholar]
  35. Kaul D. K., Roth E. F., Jr, Nagel R. L., Howard R. J., Handunnetti S. M. Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood. 1991 Aug 1;78(3):812–819. [PubMed] [Google Scholar]
  36. Kern P., Hemmer C. J., Gallati H., Neifer S., Kremsner P., Dietrich M., Porzsolt F. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis. 1992 Oct;166(4):930–934. doi: 10.1093/infdis/166.4.930. [DOI] [PubMed] [Google Scholar]
  37. Kwiatkowski D., Hill A. V., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R., Greenwood B. M. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990 Nov 17;336(8725):1201–1204. doi: 10.1016/0140-6736(90)92827-5. [DOI] [PubMed] [Google Scholar]
  38. Kwiatkowski D., Molyneux M. E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D. R., Grau G. E. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med. 1993 Feb;86(2):91–98. [PubMed] [Google Scholar]
  39. Lewallen S., Harding S. P., Ajewole J., Schulenburg W. E., Molyneux M. E., Marsh K., Usen S., White N. J., Taylor T. E. A review of the spectrum of clinical ocular fundus findings in P. falciparum malaria in African children with a proposed classification and grading system. Trans R Soc Trop Med Hyg. 1999 Nov-Dec;93(6):619–622. doi: 10.1016/s0035-9203(99)90071-8. [DOI] [PubMed] [Google Scholar]
  40. Looareesuwan S., Phillips R. E., Karbwang J., White N. J., Flegg P. J., Warrell D. A. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. Q J Med. 1990 May;75(277):471–481. [PubMed] [Google Scholar]
  41. Looareesuwan S., Warrell D. A., White N. J., Chanthavanich P., Warrell M. J., Chantaratherakitti S., Changswek S., Chongmankongcheep L., Kanchanaranya C. Retinal hemorrhage, a common sign of prognostic significance in cerebral malaria. Am J Trop Med Hyg. 1983 Sep;32(5):911–915. doi: 10.4269/ajtmh.1983.32.911. [DOI] [PubMed] [Google Scholar]
  42. Looareesuwan S., Wilairatana P., Krishna S., Kendall B., Vannaphan S., Viravan C., White N. J. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis. 1995 Aug;21(2):300–309. doi: 10.1093/clinids/21.2.300. [DOI] [PubMed] [Google Scholar]
  43. Luijckx G. J., De Krom M. C., Takx-Kohlen B. C. Does chloroquine cause seizures? Presentation of three new cases and a review of the literature. Seizure. 1992 Sep;1(3):183–185. doi: 10.1016/1059-1311(92)90023-t. [DOI] [PubMed] [Google Scholar]
  44. MacPherson G. G., Warrell M. J., White N. J., Looareesuwan S., Warrell D. A. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol. 1985 Jun;119(3):385–401. [PMC free article] [PubMed] [Google Scholar]
  45. Marsh K., Forster D., Waruiru C., Mwangi I., Winstanley M., Marsh V., Newton C., Winstanley P., Warn P., Peshu N. Indicators of life-threatening malaria in African children. N Engl J Med. 1995 May 25;332(21):1399–1404. doi: 10.1056/NEJM199505253322102. [DOI] [PubMed] [Google Scholar]
  46. Marsh K., Marsh V. M., Brown J., Whittle H. C., Greenwood B. M. Plasmodium falciparum: the behavior of clinical isolates in an in vitro model of infected red blood cell sequestration. Exp Parasitol. 1988 Apr;65(2):202–208. doi: 10.1016/0014-4894(88)90123-3. [DOI] [PubMed] [Google Scholar]
  47. McCaslin R. I., Pikis A., Rodriguez W. J. Pediatric Plasmodium falciparium malaria: a ten-year experience from Washington, DC. Pediatr Infect Dis J. 1994 Aug;13(8):709–715. [PubMed] [Google Scholar]
  48. McGuire W., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994 Oct 6;371(6497):508–510. doi: 10.1038/371508a0. [DOI] [PubMed] [Google Scholar]
  49. McGuire W., Knight J. C., Hill A. V., Allsopp C. E., Greenwood B. M., Kwiatkowski D. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis. 1999 Jan;179(1):287–290. doi: 10.1086/314533. [DOI] [PubMed] [Google Scholar]
  50. McIntosh H. M., Olliaro P. Treatment of severe malaria with artemisinin derivatives. A systematic review of randomised controlled trials. Med Trop (Mars) 1998;58(3 Suppl):61–62. [PubMed] [Google Scholar]
  51. Miller K. D., Greenberg A. E., Campbell C. C. Treatment of severe malaria in the United States with a continuous infusion of quinidine gluconate and exchange transfusion. N Engl J Med. 1989 Jul 13;321(2):65–70. doi: 10.1056/NEJM198907133210201. [DOI] [PubMed] [Google Scholar]
  52. Molyneux M. E., Taylor T. E., Wirima J. J., Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989 May;71(265):441–459. [PubMed] [Google Scholar]
  53. Murphy S. A., Mberu E., Muhia D., English M., Crawley J., Waruiru C., Lowe B., Newton C. R., Winstanley P., Marsh K. The disposition of intramuscular artemether in children with cerebral malaria; a preliminary study. Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):331–334. doi: 10.1016/s0035-9203(97)90097-3. [DOI] [PubMed] [Google Scholar]
  54. Nash G. B., Cooke B. M., Marsh K., Berendt A., Newbold C., Stuart J. Rheological analysis of the adhesive interactions of red blood cells parasitized by Plasmodium falciparum. Blood. 1992 Feb 1;79(3):798–807. [PubMed] [Google Scholar]
  55. Newbold C., Warn P., Black G., Berendt A., Craig A., Snow B., Msobo M., Peshu N., Marsh K. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg. 1997 Oct;57(4):389–398. doi: 10.4269/ajtmh.1997.57.389. [DOI] [PubMed] [Google Scholar]
  56. Newton C. R., Chokwe T., Schellenberg J. A., Winstanley P. A., Forster D., Peshu N., Kirkham F. J., Marsh K. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg. 1997 Mar-Apr;91(2):161–165. doi: 10.1016/s0035-9203(97)90207-8. [DOI] [PubMed] [Google Scholar]
  57. Newton C. R., Crawley J., Sowumni A., Waruiru C., Mwangi I., English M., Murphy S., Winstanley P. A., Marsh K., Kirkham F. J. Intracranial hypertension in Africans with cerebral malaria. Arch Dis Child. 1997 Mar;76(3):219–226. doi: 10.1136/adc.76.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Newton C. R., Kirkham F. J., Winstanley P. A., Pasvol G., Peshu N., Warrell D. A., Marsh K. Intracranial pressure in African children with cerebral malaria. Lancet. 1991 Mar 9;337(8741):573–576. doi: 10.1016/0140-6736(91)91638-b. [DOI] [PubMed] [Google Scholar]
  59. Newton C. R., Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998 Jul;79(1):1–53. doi: 10.1016/s0163-7258(98)00008-4. [DOI] [PubMed] [Google Scholar]
  60. Newton C. R., Marsh K., Peshu N., Kirkham F. J. Perturbations of cerebral hemodynamics in Kenyans with cerebral malaria. Pediatr Neurol. 1996 Jul;15(1):41–49. doi: 10.1016/0887-8994(96)00115-4. [DOI] [PubMed] [Google Scholar]
  61. Newton C. R., Peshu N., Kendall B., Kirkham F. J., Sowunmi A., Waruiru C., Mwangi I., Murphy S. A., Marsh K. Brain swelling and ischaemia in Kenyans with cerebral malaria. Arch Dis Child. 1994 Apr;70(4):281–287. doi: 10.1136/adc.70.4.281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Nussler A. K., Eling W., Kremsher P. G. Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. J Infect Dis. 1994 Jun;169(6):1418–1419. doi: 10.1093/infdis/169.6.1418. [DOI] [PubMed] [Google Scholar]
  63. Ockenhouse C. F., Ho M., Tandon N. N., Van Seventer G. A., Shaw S., White N. J., Jamieson G. A., Chulay J. D., Webster H. K. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis. 1991 Jul;164(1):163–169. doi: 10.1093/infdis/164.1.163. [DOI] [PubMed] [Google Scholar]
  64. Omanga U., Ntihinyurwa M., Shako D., Mashako M. Les hémiplégies au cours de l'accès pernicieux à plasmodium falciparum de l'enfant. Ann Pediatr (Paris) 1983 Apr;30(4):294–296. [PubMed] [Google Scholar]
  65. Phillips R. E., Warrell D. A., White N. J., Looareesuwan S., Karbwang J. Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies. N Engl J Med. 1985 May 16;312(20):1273–1278. doi: 10.1056/NEJM198505163122001. [DOI] [PubMed] [Google Scholar]
  66. Riganti M., Pongponratn E., Tegoshi T., Looareesuwan S., Punpoowong B., Aikawa M. Human cerebral malaria in Thailand: a clinico-pathological correlation. Immunol Lett. 1990 Aug;25(1-3):199–205. doi: 10.1016/0165-2478(90)90115-7. [DOI] [PubMed] [Google Scholar]
  67. Rogerson S. J., Tembenu R., Dobaño C., Plitt S., Taylor T. E., Molyneux M. E. Cytoadherence characteristics of Plasmodium falciparum-infected erythrocytes from Malawian children with severe and uncomplicated malaria. Am J Trop Med Hyg. 1999 Sep;61(3):467–472. doi: 10.4269/ajtmh.1999.61.467. [DOI] [PubMed] [Google Scholar]
  68. Rowe A., Obeiro J., Newbold C. I., Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995 Jun;63(6):2323–2326. doi: 10.1128/iai.63.6.2323-2326.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Rowe A., Obeiro J., Newbold C. I., Marsh K. Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun. 1995 Jun;63(6):2323–2326. doi: 10.1128/iai.63.6.2323-2326.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Silamut K., Phu N. H., Whitty C., Turner G. D., Louwrier K., Mai N. T., Simpson J. A., Hien T. T., White N. J. A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol. 1999 Aug;155(2):395–410. doi: 10.1016/S0002-9440(10)65136-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Silamut K., White N. J. Relation of the stage of parasite development in the peripheral blood to prognosis in severe falciparum malaria. Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):436–443. doi: 10.1016/0035-9203(93)90028-o. [DOI] [PubMed] [Google Scholar]
  72. Taylor A. M., Day N. P., Sinh D. X., Loc P. P., Mai T. T., Chau T. T., Phu N. H., Hien T. T., White N. J. Reactive nitrogen intermediates and outcome in severe adult malaria. Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):170–175. doi: 10.1016/s0035-9203(98)90733-7. [DOI] [PubMed] [Google Scholar]
  73. Taylor T. E., Molyneux M. E., Wirima J. J., Fletcher K. A., Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. N Engl J Med. 1988 Oct 20;319(16):1040–1047. doi: 10.1056/NEJM198810203191602. [DOI] [PubMed] [Google Scholar]
  74. Thuma P. E., Mabeza G. F., Biemba G., Bhat G. J., McLaren C. E., Moyo V. M., Zulu S., Khumalo H., Mabeza P., M'Hango A. Effect of iron chelation therapy on mortality in Zambian children with cerebral malaria. Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):214–218. doi: 10.1016/s0035-9203(98)90753-2. [DOI] [PubMed] [Google Scholar]
  75. Toro G., Román G. Cerebral malaria. A disseminated vasculomyelinopathy. Arch Neurol. 1978 May;35(5):271–275. doi: 10.1001/archneur.1978.00500290017004. [DOI] [PubMed] [Google Scholar]
  76. Tran T. H., Day N. P., Nguyen H. P., Nguyen T. H., Tran T. H., Pham P. L., Dinh X. S., Ly V. C., Ha V., Waller D. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996 Jul 11;335(2):76–83. doi: 10.1056/NEJM199607113350202. [DOI] [PubMed] [Google Scholar]
  77. Treutiger C. J., Hedlund I., Helmby H., Carlson J., Jepson A., Twumasi P., Kwiatkowski D., Greenwood B. M., Wahlgren M. Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg. 1992 May;46(5):503–510. doi: 10.4269/ajtmh.1992.46.503. [DOI] [PubMed] [Google Scholar]
  78. Turner G. D., Morrison H., Jones M., Davis T. M., Looareesuwan S., Buley I. D., Gatter K. C., Newbold C. I., Pukritayakamee S., Nagachinta B. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol. 1994 Nov;145(5):1057–1069. [PMC free article] [PubMed] [Google Scholar]
  79. Walker O., Salako L. A., Sowunmi A., Thomas J. O., Sodeine O., Bondi F. S. Prognostic risk factors and post mortem findings in cerebral malaria in children. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):491–493. doi: 10.1016/0035-9203(92)90082-n. [DOI] [PubMed] [Google Scholar]
  80. Waller D., Crawley J., Nosten F., Chapman D., Krishna S., Craddock C., Brewster D., White N. J. Intracranial pressure in childhood cerebral malaria. Trans R Soc Trop Med Hyg. 1991 May-Jun;85(3):362–364. doi: 10.1016/0035-9203(91)90291-6. [DOI] [PubMed] [Google Scholar]
  81. Waller D., Krishna S., Crawley J., Miller K., Nosten F., Chapman D., ter Kuile F. O., Craddock C., Berry C., Holloway P. A. Clinical features and outcome of severe malaria in Gambian children. Clin Infect Dis. 1995 Sep;21(3):577–587. doi: 10.1093/clinids/21.3.577. [DOI] [PubMed] [Google Scholar]
  82. Warrell D. A., Looareesuwan S., Warrell M. J., Kasemsarn P., Intaraprasert R., Bunnag D., Harinasuta T. Dexamethasone proves deleterious in cerebral malaria. A double-blind trial in 100 comatose patients. N Engl J Med. 1982 Feb 11;306(6):313–319. doi: 10.1056/NEJM198202113060601. [DOI] [PubMed] [Google Scholar]
  83. Waruiru C. M., Newton C. R., Forster D., New L., Winstanley P., Mwangi I., Marsh V., Winstanley M., Snow R. W., Marsh K. Epileptic seizures and malaria in Kenyan children. Trans R Soc Trop Med Hyg. 1996 Mar-Apr;90(2):152–155. doi: 10.1016/s0035-9203(96)90120-0. [DOI] [PubMed] [Google Scholar]
  84. Wattanagoon Y., Srivilairit S., Looareesuwan S., White N. J. Convulsions in childhood malaria. Trans R Soc Trop Med Hyg. 1994 Jul-Aug;88(4):426–428. doi: 10.1016/0035-9203(94)90415-4. [DOI] [PubMed] [Google Scholar]
  85. Weiss G., Thuma P. E., Biemba G., Mabeza G., Werner E. R., Gordeuk V. R. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis. 1998 Apr;177(4):1064–1068. doi: 10.1086/515229. [DOI] [PubMed] [Google Scholar]
  86. White N. J., Ho M. The pathophysiology of malaria. Adv Parasitol. 1992;31:83–173. doi: 10.1016/s0065-308x(08)60021-4. [DOI] [PubMed] [Google Scholar]
  87. White N. J., Looareesuwan S., Phillips R. E., Chanthavanich P., Warrell D. A. Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet. 1988 Jul 9;2(8602):64–66. doi: 10.1016/s0140-6736(88)90002-5. [DOI] [PubMed] [Google Scholar]
  88. White N. J., Looareesuwan S., Warrell D. A., Warrell M. J., Bunnag D., Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated Falciparum malaria. Am J Med. 1982 Oct;73(4):564–572. doi: 10.1016/0002-9343(82)90337-0. [DOI] [PubMed] [Google Scholar]
  89. White N. J., Looareesuwan S., Warrell D. A., Warrell M. J., Chanthavanich P., Bunnag D., Harinasuta T. Quinine loading dose in cerebral malaria. Am J Trop Med Hyg. 1983 Jan;32(1):1–5. doi: 10.4269/ajtmh.1983.32.1. [DOI] [PubMed] [Google Scholar]
  90. White N. J. Lumbar puncture in cerebral malaria. Lancet. 1991 Sep 7;338(8767):640–641. doi: 10.1016/0140-6736(91)90654-8. [DOI] [PubMed] [Google Scholar]
  91. White N. J. The treatment of malaria. N Engl J Med. 1996 Sep 12;335(11):800–806. doi: 10.1056/NEJM199609123351107. [DOI] [PubMed] [Google Scholar]
  92. White N. J., Warrell D. A., Chanthavanich P., Looareesuwan S., Warrell M. J., Krishna S., Williamson D. H., Turner R. C. Severe hypoglycemia and hyperinsulinemia in falciparum malaria. N Engl J Med. 1983 Jul 14;309(2):61–66. doi: 10.1056/NEJM198307143090201. [DOI] [PubMed] [Google Scholar]
  93. Winstanley P. A., Mberu E. K., Watkins W. M., Murphy S. A., Lowe B., Marsh K. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: unbound quinine concentrations following a simple loading dose regimen. Trans R Soc Trop Med Hyg. 1994 Sep-Oct;88(5):577–580. doi: 10.1016/0035-9203(94)90170-8. [DOI] [PubMed] [Google Scholar]
  94. Winstanley P. A., Newton C. R., Pasvol G., Kirkham F. J., Mberu E., Peshu N., Ward S. A., Were J. B., Warrell D. A., Marsh K. Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects. Br J Clin Pharmacol. 1992 Feb;33(2):149–154. doi: 10.1111/j.1365-2125.1992.tb04017.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. al-Yaman F. M., Genton B., Clark I. A. The ratio of reactive nitrogen intermediates to tumour necrosis factor and clinical outcome of falciparum malaria disease. Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):417–420. doi: 10.1016/s0035-9203(98)91073-2. [DOI] [PubMed] [Google Scholar]
  96. van Hensbroek M. B., Onyiorah E., Jaffar S., Schneider G., Palmer A., Frenkel J., Enwere G., Forck S., Nusmeijer A., Bennett S. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med. 1996 Jul 11;335(2):69–75. doi: 10.1056/NEJM199607113350201. [DOI] [PubMed] [Google Scholar]
  97. van Hensbroek M. B., Palmer A., Onyiorah E., Schneider G., Jaffar S., Dolan G., Memming H., Frenkel J., Enwere G., Bennett S. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis. 1996 Nov;174(5):1091–1097. doi: 10.1093/infdis/174.5.1091. [DOI] [PubMed] [Google Scholar]
  98. van der Torn M., Thuma P. E., Mabeza G. F., Biemba G., Moyo V. M., McLaren C. E., Brittenham G. M., Gordeuk V. R. Loading dose of quinine in African children with cerebral malaria. Trans R Soc Trop Med Hyg. 1998 May-Jun;92(3):325–331. doi: 10.1016/s0035-9203(98)91032-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES